Medindia LOGIN REGISTER
Medindia

Omega-3s Content – DHA is Found to Worsen Cardiovascular Health

by Karishma Abhishek on May 18 2021 11:52 PM

Higher Omega-3s content – EPA blood levels alone lowered the risk of major cardiac events and death in patients, while DHA blunted the cardiovascular benefits of EPA.

Omega-3s Content – DHA is Found to Worsen Cardiovascular Health
Omega-3s is often recommended by doctors to help patients lower their cholesterol and improve heart health. The sources of these Omega-3s come from fatty fish like salmon and mackerel, or supplements that often contain a combination of the acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
It is seen that higher EPA blood levels alone lowered the risk of major cardiac events and death in patients, while DHA blunted the cardiovascular benefits of EPA. Higher DHA levels at any level of EPA, worsened health outcomes as per an Intermountain study, presented virtually at the 2021 American College of Cardiology's Scientific Session.

"The advice to take Omega-3s for the good of your heart is pervasive, but previous studies have shown that science doesn't really back this up for every single omega-3. Our findings show that not all Omega-3s are alike, and that EPA and DHA combined together, as they often are in supplements, may void the benefits that patients and their doctors hope to achieve," says Viet T. Le, MPAS, PA, researcher and cardiovascular physician assistant at the Intermountain Heart Institute and principal investigator of the study.

EPA and DHA in Blood

The present study examined nearly 1,000 patients over a 10-year-period using the INSPIRE registry, an Intermountain Healthcare database started in 1993 that has more than 35,000 blood samples from nearly 25,000 patients. From the registry, the team had identified 987 patients who underwent their first documented coronary angiographic study at Intermountain Healthcare between 1994 and 2012.

From those blood samples, the circulating levels of EPA and DHA in their blood were measured. These patients were then tracked for 10 years, looking for major cardiac adverse events, which included heart attack, stroke, and heart failure requiring hospitalization or death.

It was found that patients with the highest levels of EPA had a reduced risk of major heart events. When evaluating how EPA and DHA affect one another, they found that higher DHA blunts the benefit of EPA. In particular, they also found that those patients with higher levels of DHA than EPA were more at risk for heart problems.

Advertisement
Further feasibility for use of the combined EPA/DHA, particularly through supplements adds to the concern.

"Based on these and other findings, we can still tell our patients to eat Omega-3 rich foods, but we should not be recommending them in pill form as supplements or even as combined (EPA + DHA) prescription products. Our data adds further strength to the findings of the recent REDUCE-IT (2018) study that EPA-only prescription products reduce heart disease events," says Le.

Advertisement
Source-Medindia


Advertisement